First Turn Management »

Vera Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 327k 44.20
2024-03-31 $5.1M 118k 43.12

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Vera Therapeutics

venBio Select Advisor
T. Rowe Price Associates
BlackRock
Sofinnova Ventures
FMR
Vanguard Group
Commodore Capital
Eversept Partners
Holocene Advisors
State Street Corporation
Kynam Capital Management
Adage Capital Partners GP
Samlyn Capital
Paradigm Biocapital Advisors
Geode Capital Management

View all funds holding Vera Therapeutics